Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Chisholm

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Pediatric Surgery|April 29, 2026
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European paediatric Soft-tissue sarcoma Study Group (EpSSG)Naima Smeulders, Mark N Gaze, Florent Guérin, et al.
BMJ Open|December 21, 2023
Research priorities for children's cancer: a James Lind Alliance Priority Setting Partnership in the UKSusie Aldiss, Rachel Hollis, Bob Phillips, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). <i>Cancers</i> 2024, <i>16</i>, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Journal of Medical Genetics|January 27, 2011
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndromeIngrid Slade, Chiara Bacchelli, Helen Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
British Journal of Cancer|June 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcomaJoseph S Baxter, Claudia Montiel Equihua, Jan J Molenaar, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Pediatric Surgery|April 29, 2026
Surgical nodal staging in rhabdomyosarcoma of the bladder and/or prostate with or without nodal or metastatic spread. A report from the European paediatric Soft-tissue sarcoma Study Group (EpSSG)Naima Smeulders, Mark N Gaze, Florent Guérin, et al.
BMJ Open|December 21, 2023
Research priorities for children's cancer: a James Lind Alliance Priority Setting Partnership in the UKSusie Aldiss, Rachel Hollis, Bob Phillips, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). <i>Cancers</i> 2024, <i>16</i>, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Journal of Medical Genetics|January 27, 2011
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndromeIngrid Slade, Chiara Bacchelli, Helen Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2021
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F Shern, Joanna Selfe, Elisa Izquierdo, et al.
Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
British Journal of Cancer|June 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcomaJoseph S Baxter, Claudia Montiel Equihua, Jan J Molenaar, et al.
Pageof 5